STAT Plus: AI startups are racing into drug development. Here’s 5 burning questions about which will survive
ADOBE
Industry executives and VCs told STAT they’re watching closely for signs of which companies will succeed in an increasingly crowded market.
No hay comentarios:
Publicar un comentario